-
Mashup Score: 65Botulinum toxin injection shows promise in nail psoriasis: A comparative randomized controlled trial - 23 day(s) ago
Nail psoriasis remains a challenging condition with limited satisfaction from current treatments. An increasing number of neuropeptides were reported in psoriatic tissue.
Source: www.jaadinternational.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 50Bicalutamide 25 mg combined with minoxidil 1 mg versus minoxidil 1 mg for female pattern hair loss: A randomized double-blind clinical trial - 1 month(s) ago
Antiandrogenic drugs are often used to treat female pattern hair loss (FPHL) despite limited evidence supporting their use. There is growing interest in bicalutamide for this purpose, but its efficacy in treating FPHL has not been evaluated in clinical trials.
Source: www.jaadinternational.orgCategories: General Medicine News, Partners & KOLsTweet-
This JAAD International study assessed the efficacy of 25 mg/d bicalutamide combined with 1 mg/d minoxidil compared to 1 mg/d minoxidil monotherapy over 24 weeks for FPHL treatment: https://t.co/gwNGNCPHyP https://t.co/67DtfY5cZ8
-
-
Mashup Score: 5
To the Editor: Drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS) is a severe systemic cutaneous adverse drug eruption, in which cytomegalovirus (CMV) disease is a major prognostic indicator.1,2 However, the factors influencing the progression to CMV disease are poorly understood, and several attempts have been made to predict the development of CMV disease in DIHS/DRESS, including the establishment of a scoring system, the DIHS/DRESS severity score.
Source: www.jaadinternational.orgCategories: General Medicine News, Partners & KOLsTweet-
Drug-induced hypersensitivity syndrome (DIHS/DRESS) is a reaction to medication and CMV disease is a key prognostic factor. But what drives CMV progression in DIHS/DRESS? Read the JAAD International article: https://t.co/TsZJWejlTx https://t.co/VUvFESPwSp
-
-
Mashup Score: 1Call for papers: JAAD International - 1 year(s) ago
The past decades have been a golden era for psoriasis therapeutics as our understanding of both epidemiology and approaches to management have matured and evolved. This VSI will focus on all aspects of psoriasis, from basic science through epidemiology and treatment options, and manuscripts are welcomed and encouraged from around the world. Dr. Jonathan Kantor, MD, MSCE University of Pennsylvania, Philadelphia, Pennsylvania, United States of America JAAD International’s submission system is open for
Source: www.jaadinternational.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @ELS_Dermatology: Deadline extended! Don't miss this exciting opportunity! Submit your research today! https://t.co/fYArPeoyzw @JAADjou…
-
-
Mashup Score: 1Call for papers: JAAD International - 1 year(s) ago
The past decades have been a golden era for psoriasis therapeutics as our understanding of both epidemiology and approaches to management have matured and evolved. This VSI will focus on all aspects of psoriasis, from basic science through epidemiology and treatment options, and manuscripts are welcomed and encouraged from around the world. Dr. Jonathan Kantor, MD, MSCE University of Pennsylvania, Philadelphia, Pennsylvania, United States of America JAAD International’s submission system is open for
Source: www.jaadinternational.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @ELS_Dermatology: Deadline extended! Don't miss this exciting opportunity! Submit your research today! https://t.co/fYArPeoyzw @JAADjou…
-
-
Mashup Score: 1Call for papers: JAAD International - 1 year(s) ago
The past decades have been a golden era for psoriasis therapeutics as our understanding of both epidemiology and approaches to management have matured and evolved. This VSI will focus on all aspects of psoriasis, from basic science through epidemiology and treatment options, and manuscripts are welcomed and encouraged from around the world. Dr. Jonathan Kantor, MD, MSCE University of Pennsylvania, Philadelphia, Pennsylvania, United States of America JAAD International’s submission system is open for
Source: www.jaadinternational.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @ELS_Dermatology: Deadline extended! Don't miss this exciting opportunity! Submit your research today! https://t.co/fYArPeoyzw @JAADjou…
-
-
Mashup Score: 1Call for papers: JAAD International - 1 year(s) ago
The past decades have been a golden era for psoriasis therapeutics as our understanding of both epidemiology and approaches to management have matured and evolved. This VSI will focus on all aspects of psoriasis, from basic science through epidemiology and treatment options, and manuscripts are welcomed and encouraged from around the world. Dr. Jonathan Kantor, MD, MSCE University of Pennsylvania, Philadelphia, Pennsylvania, United States of America JAAD International’s submission system is open for
Source: www.jaadinternational.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @ELS_Dermatology: Deadline extended! Don't miss this exciting opportunity! Submit your research today! https://t.co/fYArPeoyzw @JAADjou…
-
-
Mashup Score: 1Call for papers: JAAD International - 1 year(s) ago
The past decades have been a golden era for psoriasis therapeutics as our understanding of both epidemiology and approaches to management have matured and evolved. This VSI will focus on all aspects of psoriasis, from basic science through epidemiology and treatment options, and manuscripts are welcomed and encouraged from around the world. Dr. Jonathan Kantor, MD, MSCE University of Pennsylvania, Philadelphia, Pennsylvania, United States of America JAAD International’s submission system is open for
Source: www.jaadinternational.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @ELS_Dermatology: Deadline extended! Don't miss this exciting opportunity! Submit your research today! https://t.co/fYArPeoyzw @JAADjou…
-
-
Mashup Score: 1Call for papers: JAAD International - 1 year(s) ago
The past decades have been a golden era for psoriasis therapeutics as our understanding of both epidemiology and approaches to management have matured and evolved. This VSI will focus on all aspects of psoriasis, from basic science through epidemiology and treatment options, and manuscripts are welcomed and encouraged from around the world. Dr. Jonathan Kantor, MD, MSCE University of Pennsylvania, Philadelphia, Pennsylvania, United States of America JAAD International’s submission system is open for
Source: www.jaadinternational.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @ELS_Dermatology: Deadline extended! Don't miss this exciting opportunity! Submit your research today! https://t.co/fYArPeoyzw @JAADjou…
-
-
Mashup Score: 1Call for papers: JAAD International - 1 year(s) ago
The past decades have been a golden era for psoriasis therapeutics as our understanding of both epidemiology and approaches to management have matured and evolved. This VSI will focus on all aspects of psoriasis, from basic science through epidemiology and treatment options, and manuscripts are welcomed and encouraged from around the world. Dr. Jonathan Kantor, MD, MSCE University of Pennsylvania, Philadelphia, Pennsylvania, United States of America JAAD International’s submission system is open for
Source: www.jaadinternational.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @ELS_Dermatology: Deadline extended! Don't miss this exciting opportunity! Submit your research today! https://t.co/fYArPeoyzw @JAADjou…
-
Botulinum toxin A injections showed the most effective improvement in nail psoriasis, outperforming steroid injections, topical treatments, and placebo — with a 40% reduction in total target NAPSI score at 24 weeks. Read more in JAADi: https://t.co/9a6jUq6qv5 https://t.co/rtSRbLBTpy